Insight

Nathan Cherny on the ongoing disparities in access to essential cancer medicines – ESMO

Nathan Cherny/dailyreporter.esmo.org

Feb 12, 2025, 09:49

Nathan Cherny on the ongoing disparities in access to essential cancer medicines – ESMO

ESMO (European Society for Medical Oncology) shared their earlier post on LinkedIn, adding:

“Nathan Cherny, co-first author of the ‘ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update’ sheds light on the ongoing disparities in access to essential cancer medicines.

‘Despite efforts to ensure equitable access to cancer medicines, the landscape remains largely unchanged. We need more effective action.’

He urges policymakers, NGOs and medical oncologists worldwide to use the updated data to ensure equitable access to high-quality cancer treatment for all patients.

Read the full interview in the ESMO Daily Reporter.”

Quoting ESMO’s earlier post: about a paper by Nathan Cherny et al. published in Annals Of Oncology:

“The results of the ‘ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update’ are now available in Annals Of Oncology.

This is the largest-ever survey of its type addressing the critical issue of accessibility to Cancer Medicines, focusing on the availability and affordability of safe and effective therapies for patients with cancer.

As medicine availability directly impacts clinicians’ daily practice and their ability to provide care, this study confirms ESMO’s commitment to ensuring timely and optimal treatment opportunities for patients with cancer.

Check out the results.”

“ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update”

Authors: Nathan Cherny et al.

Nathan Cherny on the ongoing disparities in access to essential cancer medicines - ESMO